Caerulum Pharma Discovery established its first chemical synthesis laboratory in 2012. Currently, it operates 5 standard chemical laboratories, 2 pilot-scale laboratories, an analytical instrumenutal room, and a DMPK laboratory in Shanghai. The laboratories are equipped with advanced instruments such as LCMS, NMR, HPLC, and GC, covering a total area of over 1000 square meters. The environment is spacious, well-lit, and well-ventilated. The campus offers a beautiful setting, convenient transportation, and a rich variety of recreational activities for employees.
In 2017, Caerulum Pharma Discovery further expanded its service offerings by adding outsourced biological services, including in vitro biological screening, in vivo efficacy evaluation, and non-GLP safety assessments. This expansion provides clients with a more diverse range of services and enhanced facilities, significantly improving the overall process of our one-stop preclinical drug discovery and development services.
